HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guerlain

This article was originally published in The Rose Sheet

Executive Summary

Extending Evolution skin care line with Sublilift A.R.T. Recontouring Serum and Exfoliating Creme for the face and Bodyferm A.R.T. Recontouring Care and Exfoliating Gel for the body. Both Sublilift and Bodyferm contain Guerlain's "A.R.T. complex," which "serves to prevent the deterioration of elastin and preserves the suppleness of collagen" and "neutralizes free radicals," the company says. Ingredients in the complex include centella Asiatica extract, tocopherol acetate and linoleate, retinyl palmitate, gingko biloba extract and bio-hyaluronic acid. The exfoliating products are effective in "polishing and irrigating the skin" to make it more receptive to the "A.R.T. complex." Each pair of firming and exfoliating products for the face or body is designed to be used together, Guerlain says. Available in May, the products have suggested retail prices ranging from $25 for the 1.7 oz. Exfoliating Creme to $55 for the 1 oz. Sublilift A.R.T. Recontouring Serum for the Face
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000102

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel